Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk

A large study found women taking GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound had a 30% lower breast cancer risk. Researchers note the findings are promising but not definitive, with clinical trials planned to test the drugs' preventive potential.